Ignite Creation Date:
2025-12-25 @ 3:38 AM
Ignite Modification Date:
2025-12-26 @ 2:22 AM
Study NCT ID:
NCT00299702
Status:
COMPLETED
Last Update Posted:
2011-12-30
First Post:
2006-03-03
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Evaluation of Effectiveness of Risperdal® Consta® Compared to Abilify® Over a Two-year Period in Patients With Schizophrenia
Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-02
Start Date Type:
None
Primary Completion Date:
2009-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-01
Completion Date Type:
ACTUAL
First Submit Date:
2006-03-03
First Submit QC Date:
None
Study First Post Date:
2006-03-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2010-01-26
Results First Submit QC Date:
None
Results First Post Date:
2010-03-16
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-12-22
Last Update Post Date:
2011-12-30
Last Update Post Date Type:
ESTIMATED